{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T09:15:19Z","timestamp":1743066919502,"version":"3.40.3"},"publisher-location":"Singapore","reference-count":122,"publisher":"Springer Nature Singapore","isbn-type":[{"type":"print","value":"9789819728589"},{"type":"electronic","value":"9789819728596"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-981-97-2859-6_2","type":"book-chapter","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T04:02:25Z","timestamp":1725595345000},"page":"15-41","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Challenges of Brain Targeting and Mechanism of Drug Transfer Across Brain Barriers"],"prefix":"10.1007","author":[{"given":"Ana Catarina","family":"Duarte","sequence":"first","affiliation":[]},{"given":"Rafael","family":"Mineiro","sequence":"additional","affiliation":[]},{"given":"Cec\u00edlia","family":"Santos","sequence":"additional","affiliation":[]},{"given":"Diana","family":"Costa","sequence":"additional","affiliation":[]},{"given":"Telma","family":"Quintela","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,9,7]]},"reference":[{"issue":"1","key":"2_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrn1824","volume":"7","author":"NJ Abbott","year":"2006","unstructured":"Abbott NJ, R\u00f6nnb\u00e4ck L, Hansson E (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7(1):41\u201353","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"2_CR2","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1021\/acs.molpharmaceut.8b01189","volume":"16","author":"ZM Al-Majdoub","year":"2019","unstructured":"Al-Majdoub ZM, Al Feteisi H, Achour B, Warwood S, Neuhoff S, Rostami-Hodjegan A et al (2019) Proteomic quantification of human blood-brain barrier SLC and ABC transporters in healthy individuals and dementia patients. Mol Pharm 16(3):1220\u20131233","journal-title":"Mol Pharm"},{"issue":"23","key":"2_CR3","doi-asserted-by":"publisher","first-page":"5981","DOI":"10.1111\/febs.12335","volume":"280","author":"PMA Antony","year":"2013","unstructured":"Antony PMA, Diederich NJ, Kr\u00fcger R, Balling R (2013) The hallmarks of Parkinson\u2019s disease. FEBS J 280(23):5981\u20135993","journal-title":"FEBS J"},{"issue":"7323","key":"2_CR4","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature09522","volume":"468","author":"A Armulik","year":"2010","unstructured":"Armulik A, Genov\u00e9 G, M\u00e4e M, Nisancioglu MH, Wallgard E, Niaudet C et al (2010) Pericytes regulate the blood-brain barrier. Nature 468(7323):557\u2013561","journal-title":"Nature"},{"issue":"2","key":"2_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/adhm.202001375","volume":"10","author":"M Ayer","year":"2021","unstructured":"Ayer M, Schuster M, Gruber I, Blatti C, Kaba E, Enzmann G et al (2021) T cell-mediated transport of polymer nanoparticles across the blood\u2013brain barrier. Adv Healthc Mater 10(2):1\u201311","journal-title":"Adv Healthc Mater"},{"key":"2_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119582","volume":"586","author":"M Azarmi","year":"2020","unstructured":"Azarmi M, Maleki H, Nikkam N, Malekinejad H (2020) Transcellular brain drug delivery: a review on recent advancements. Int J Pharm 586:119582. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119582","journal-title":"Int J Pharm"},{"issue":"5","key":"2_CR7","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S1773-2247(13)50061-X","volume":"23","author":"EV Batrakova","year":"2013","unstructured":"Batrakova EV, Kabanov AV (2013) Cell-mediated drug delivery to the brain. J Drug Deliv Sci Technol 23(5):419\u2013433. https:\/\/doi.org\/10.1016\/S1773-2247(13)50061-X","journal-title":"J Drug Deliv Sci Technol"},{"issue":"Suppl 2","key":"2_CR8","volume":"44","author":"CM Bellettato","year":"2018","unstructured":"Bellettato CM, Scarpa M (2018) Possible strategies to cross the blood-brain barrier. Italy. J Pediatr 44(Suppl 2):1DUNNY","journal-title":"J Pediatr"},{"issue":"12","key":"2_CR9","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1038\/s41596-018-0066-x","volume":"13","author":"S Bergmann","year":"2018","unstructured":"Bergmann S, Lawler SE, Qu Y, Fadzen CM, Wolfe JM, Regan MS et al (2018) Blood-brain-barrier organoids for investigating the permeability of CNS therapeutics. Nat Protoc 13(12):2827\u20132843","journal-title":"Nat Protoc"},{"issue":"10","key":"2_CR10","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1007\/s00018-019-03030-7","volume":"76","author":"P Berndt","year":"2019","unstructured":"Berndt P, Winkler L, Cording J, Breitkreuz-Korff O, Rex A, Dithmer S et al (2019) Tight junction proteins at the blood\u2013brain barrier: far more than claudin-5. Cell Mol Life Sci 76(10):1987\u20132002. https:\/\/doi.org\/10.1007\/s00018-019-03030-7","journal-title":"Cell Mol Life Sci"},{"issue":"47","key":"2_CR11","doi-asserted-by":"publisher","first-page":"10884","DOI":"10.1523\/JNEUROSCI.2909-05.2005","volume":"25","author":"E Carro","year":"2005","unstructured":"Carro E, Spuch C, Trejo JL, Antequera D, Torres-Aleman I (2005) Choroid plexus megalin is involved in neuroprotection by serum insulin-like growth factor I. J Neurosci 25(47):10884\u201310893. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16306401","journal-title":"J Neurosci"},{"issue":"10","key":"2_CR12","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.tins.2015.08.003","volume":"38","author":"BW Chow","year":"2015","unstructured":"Chow BW, Gu C (2015) The molecular constituents of the blood-brain barrier. Trends Neurosci 38(10):598\u2013608. https:\/\/doi.org\/10.1016\/j.tins.2015.08.003","journal-title":"Trends Neurosci"},{"key":"2_CR13","doi-asserted-by":"publisher","first-page":"4709","DOI":"10.1113\/JP275489","volume":"19","author":"HL Christensen","year":"2018","unstructured":"Christensen HL, Barbuskaite D, Rojek A, Malte H, Christensen IB, Wang T et al (2018) The choroid plexus sodium-bicarbonate cotransporter NBCe2 regulates mouse cerebrospinal fluid pH. J Physiol 19:4709\u20134728","journal-title":"J Physiol"},{"key":"2_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/bs.acr.2014.10.003","volume":"125","author":"EE Chufan","year":"2015","unstructured":"Chufan EE, Sim HM, Ambudkar SV (2015) Molecular basis of the Polyspecificity of P-glycoprotein (ABCB1). Recent Biochem Struct Stud 125:71\u201396. https:\/\/doi.org\/10.1016\/bs.acr.2014.10.003","journal-title":"Recent Biochem Struct Stud"},{"issue":"16","key":"2_CR15","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1097\/00001756-200211150-00014","volume":"13","author":"HC Cooray","year":"2002","unstructured":"Cooray HC, Blackmore CG, Maskell L, Barrand MA (2002) Localisation of breast cancer resistance protein in microvessel endothelium of human brain. Neuroreport 13(16):2059\u20132063","journal-title":"Neuroreport"},{"issue":"9","key":"2_CR16","doi-asserted-by":"publisher","first-page":"6979","DOI":"10.1074\/jbc.M110.166868","volume":"286","author":"S Copsel","year":"2011","unstructured":"Copsel S, Garcia C, Diez F, Vermeulem M, Baldi A, Bianciotti LG et al (2011) Multidrug resistance protein 4 (MRP4\/ABCC4) regulates cAMP cellular levels and controls human leukemia cell proliferation and differentiation. J Biol Chem 286(9):6979\u20136988. https:\/\/doi.org\/10.1074\/jbc.M110.166868","journal-title":"J Biol Chem"},{"issue":"1","key":"2_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1602\/neurorx.2.1.27","volume":"2","author":"EM Cornford","year":"2005","unstructured":"Cornford EM, Hyman S (2005) Localization of brain endothelial luminal and abluminal transporters with immunogold electron microscopy. NeuroRx 2(1):27\u201343","journal-title":"NeuroRx"},{"issue":"4","key":"2_CR18","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1007\/s12035-020-02267-9","volume":"58","author":"AR Costa-Brito","year":"2021","unstructured":"Costa-Brito AR, Quintela T, Gon\u00e7alves I, Duarte AC, Costa AR, Arosa FA et al (2021) The choroid plexus is an alternative source of prolactin to the rat brain. Mol Neurobiol 58(4):1846\u20131858","journal-title":"Mol Neurobiol"},{"key":"2_CR19","doi-asserted-by":"crossref","unstructured":"Dabbagh F, Schroten H, Schwerk C (2022) In vitro models of the blood\u2013cerebrospinal fluid barrier and their applications in the development and research of (neuro)pharmaceuticals. Pharmaceutics 14(8)","DOI":"10.3390\/pharmaceutics14081729"},{"key":"2_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1101\/cshperspect.a020412","volume":"7","author":"R Daneman","year":"2015","unstructured":"Daneman R, Prat A (2015) The blood brain barrier. Cold Spring Harb Perspect Biol 7:21\u201338","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"4","key":"2_CR21","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1055\/s-0028-1103272","volume":"39","author":"M Daood","year":"2008","unstructured":"Daood M, Tsai C, Ahdab-Barmada M, Watchko JF (2008) ABC transporter (P-gp\/ABCB1, MRP1\/ABCC1, BCRP\/ABCG2) expression in the developing human CNS. Neuropediatrics 39(4):211\u2013218","journal-title":"Neuropediatrics"},{"issue":"6","key":"2_CR22","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1111\/j.1471-4159.2008.05720.x","volume":"107","author":"S Dauchy","year":"2008","unstructured":"Dauchy S, Dutheil F, Weaver RJ, Chassoux F, Daumas-Duport C, Couraud PO et al (2008) ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier. J Neurochem 107(6):1518\u20131528","journal-title":"J Neurochem"},{"issue":"8","key":"2_CR23","doi-asserted-by":"publisher","first-page":"732","DOI":"10.2174\/138920011798357024","volume":"12","author":"X Decleves","year":"2011","unstructured":"Decleves X, Jacob A, Yousif S, Shawahna R, Potin S, Scherrmann J-M (2011) Interplay of drug metabolizing CYP450 enzymes and ABC transporters in the blood-brain barrier. Curr Drug Metab 12(8):732\u2013741","journal-title":"Curr Drug Metab"},{"issue":"11","key":"2_CR24","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/j.bcp.2013.03.022","volume":"85","author":"D Dickens","year":"2013","unstructured":"Dickens D, Webb SD, Antonyuk S, Giannoudis A, Owen A, R\u00e4disch S et al (2013) Transport of gabapentin by LAT1 (SLC7A5). Biochem Pharmacol 85(11):1672\u20131683","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"2_CR25","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.neurobiolaging.2007.01.008","volume":"29","author":"MO Dietrich","year":"2008","unstructured":"Dietrich MO, Spuch C, Antequera D, Rodal I, de Y\u00e9benes JG, Molina JA et al (2008) Megalin mediates the transport of leptin across the blood-CSF barrier. Neurobiol Aging 29(6):902\u2013912","journal-title":"Neurobiol Aging"},{"issue":"5","key":"2_CR26","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.1074\/jbc.M112.436972","volume":"288","author":"H Duan","year":"2013","unstructured":"Duan H, Wang J (2013) Impaired monoamine and organic cation uptake in choroid plexus in mice with targeted disruption of the plasma membrane monoamine transporter (Slc29a4) gene. J Biol Chem 288(5):3535\u20133544","journal-title":"J Biol Chem"},{"key":"2_CR27","doi-asserted-by":"publisher","first-page":"113954","DOI":"10.1016\/j.bcp.2020.113954","volume":"177","author":"AC Duarte","year":"2020","unstructured":"Duarte AC, Santos J, Costa AR, Ferreira CL, Tom\u00e1s J, Quintela T et al (2020a) Bitter taste receptors profiling in the human blood-cerebrospinal fluid-barrier. Biochem Pharmacol 177:113954","journal-title":"Biochem Pharmacol"},{"key":"2_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.113953","volume":"177","author":"AC Duarte","year":"2020","unstructured":"Duarte AC, Rosado T, Costa AR, Santos J, Gallardo E, Quintela T et al (2020b) The bitter taste receptor TAS2R14 regulates resveratrol transport across the human blood-cerebrospinal fluid barrier. Biochem Pharmacol 177:113953. https:\/\/doi.org\/10.1016\/j.bcp.2020.113953","journal-title":"Biochem Pharmacol"},{"issue":"18","key":"2_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21186813","volume":"21","author":"AC Duarte","year":"2020","unstructured":"Duarte AC, Furtado A, Hrynchak MV, Costa AR, Talhada D, Gon\u00e7alves I et al (2020c) Age, sex hormones, and circadian rhythm regulate the expression of amyloid-beta scavengers at the choroid plexus. Int J Mol Sci 21(18):1\u201312","journal-title":"Int J Mol Sci"},{"key":"2_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioadv.2023.213428","volume":"151","author":"AC Duarte","year":"2023","unstructured":"Duarte AC, Costa EC, Filipe HAL, Saraiva SM, Jacinto T, Miguel SP et al (2023) Animal-derived products in science and current alternatives. Biomater Adv 151:213428","journal-title":"Biomater Adv"},{"issue":"11","key":"2_CR31","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1097\/00004647-200011000-00005","volume":"20","author":"R Duelli","year":"2000","unstructured":"Duelli R, Enerson BE, Gerhart DZ, Drewes LR (2000) Expression of large amino acid transporter LAT1 in rat brain endothelium. J Cereb Blood Flow Metab 20(11):1557\u20131562","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"2_CR32","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0165-5728(94)90082-5","volume":"51","author":"B Engelhardt","year":"1994","unstructured":"Engelhardt B, Conley FK, Butcher EC (1994) Cell adhesion molecules on vessels during inflammation in the mouse central nervous system. J Neuroimmunol 51(2):199\u2013208","journal-title":"J Neuroimmunol"},{"key":"2_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.crphar.2021.100054","volume":"2","author":"P Famta","year":"2021","unstructured":"Famta P, Shah S, Chatterjee E, Singh H, Dey B, Guru SK et al (2021) Exploring new horizons in overcoming P-glycoprotein-mediated multidrug-resistant breast cancer via nanoscale drug delivery platforms. Curr Res Pharmacol Drug Discov 2:100054. https:\/\/doi.org\/10.1016\/j.crphar.2021.100054","journal-title":"Curr Res Pharmacol Drug Discov"},{"key":"2_CR34","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.biomaterials.2016.04.021","volume":"97","author":"Z Fang","year":"2016","unstructured":"Fang Z, Chen S, Qin J, Chen B, Ni G, Chen Z et al (2016) Pluronic P85-coated poly(butylcyanoacrylate) nanoparticles overcome phenytoin resistance in P-glycoprotein overexpressing rats with lithium-pilocarpine-induced chronic temporal lobe epilepsy. Biomaterials 97:110\u2013121","journal-title":"Biomaterials"},{"issue":"5","key":"2_CR35","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","volume":"18","author":"VL Feigin","year":"2019","unstructured":"Feigin VL, Nichols E, Alam T, Bannick MS, Beghi E, Blake N et al (2019) Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol 18(5):459\u2013480","journal-title":"Lancet Neurol"},{"key":"2_CR36","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.tox.2017.05.019","volume":"386","author":"K Flores","year":"2017","unstructured":"Flores K, Manautou JE, Renfro JL (2017) Gender-specific expression of ATP-binding cassette (Abc) transporters and cytoprotective genes in mouse choroid plexus. Toxicology 386:84\u201392. https:\/\/doi.org\/10.1016\/j.tox.2017.05.019","journal-title":"Toxicology"},{"issue":"3","key":"2_CR37","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/j.1471-4159.2011.07311.x","volume":"118","author":"M Fujiyoshi","year":"2011","unstructured":"Fujiyoshi M, Tachikawa M, Ohtsuki S, Ito S, Uchida Y, Akanuma SI et al (2011) Amyloid-\u03b2 peptide(1-40) elimination from cerebrospinal fluid involves low-density lipoprotein receptor-related protein 1 at the blood-cerebrospinal fluid barrier. J Neurochem 118(3):407\u2013415","journal-title":"J Neurochem"},{"key":"2_CR38","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.3390\/ijms23052443","volume":"23","author":"A Furtado","year":"2022","unstructured":"Furtado A, Mineiro R, Duarte AC, Gon\u00e7alves I, Santos R, Quintela T (2022) The daily expression of ABCC4 at the BCSFB affects the transport of its substrate methotrexate. Int J Mol Sci 23:2443","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2_CR39","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/jnr.25164","volume":"101","author":"A Furtado","year":"2023","unstructured":"Furtado A, Esgalhado AJ, Duarte AC, Costa AR, Costa-Brito AR, Carro E et al (2023) Circadian rhythmicity of amyloid-beta-related molecules is disrupted in the choroid plexus of a female Alzheimer\u2019s disease mouse model. J Neurosci Res 101(4):524\u2013540","journal-title":"J Neurosci Res"},{"issue":"3","key":"2_CR40","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00401-018-1807-1","volume":"135","author":"JF Ghersi-Egea","year":"2018","unstructured":"Ghersi-Egea JF, Strazielle N, Catala M, Silva-Vargas V, Doetsch F, Engelhardt B (2018) Molecular anatomy and functions of the choroidal blood-cerebrospinal fluid barrier in health and disease. Acta Neuropathol 135(3):337\u2013361. https:\/\/doi.org\/10.1007\/s00401-018-1807-1","journal-title":"Acta Neuropathol"},{"issue":"8","key":"2_CR41","doi-asserted-by":"publisher","first-page":"742","DOI":"10.2174\/138920011798357051","volume":"12","author":"C Ghosh","year":"2011","unstructured":"Ghosh C, Puvenna V, Gonzalez-Martinez J, Janigro D, Marchi N (2011) Blood-brain barrier P450 enzymes and multidrug transporters in drug resistance: a synergistic role in neurological diseases. Curr Drug Metab 12(8):742\u2013749","journal-title":"Curr Drug Metab"},{"key":"2_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107554","volume":"213","author":"E Gil-Martins","year":"2020","unstructured":"Gil-Martins E, Barbosa DJ, Silva V, Remi\u00e3o F, Silva R (2020) Dysfunction of ABC transporters at the blood-brain barrier: role in neurological disorders. Pharmacol Ther 213:107554. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107554","journal-title":"Pharmacol Ther"},{"issue":"4","key":"2_CR43","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s13346-017-0368-5","volume":"7","author":"J Gu","year":"2017","unstructured":"Gu J, Al-Bayati K, Ho EA (2017) Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes. Drug Deliv Transl Res 7(4):497\u2013506","journal-title":"Drug Deliv Transl Res"},{"key":"2_CR44","doi-asserted-by":"crossref","unstructured":"G\u00fcnzel D, Yu ASL (2013) Claudins and the modulation of tight junction permeability. Physiol Rev 93:525\u2013569","DOI":"10.1152\/physrev.00019.2012"},{"key":"2_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2021.102494","volume":"40","author":"J Halder","year":"2022","unstructured":"Halder J, Pradhan D, Kar B, Ghosh G, Rath G (2022) Nanotherapeutics approaches to overcome P-glycoprotein-mediated multi-drug resistance in cancer. Nanomed Nanotechnol Biol Med 40:102494. https:\/\/doi.org\/10.1016\/j.nano.2021.102494","journal-title":"Nanomed Nanotechnol Biol Med"},{"issue":"1","key":"2_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/iub.573","volume":"64","author":"AP Halestrap","year":"2012","unstructured":"Halestrap AP (2012) The monocarboxylate transporter family-structure and functional characterization. IUBMB Life 64(1):1\u20139","journal-title":"IUBMB Life"},{"issue":"4","key":"2_CR47","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL et al (2015) Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol 14(4):388\u2013405","journal-title":"Lancet Neurol"},{"issue":"3","key":"2_CR48","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1208\/s12248-008-9055-2","volume":"10","author":"F Herv\u00e9","year":"2008","unstructured":"Herv\u00e9 F, Ghinea N, Scherrmann JM (2008) CNS delivery via adsorptive transcytosis. AAPS J 10(3):455\u2013472","journal-title":"AAPS J"},{"issue":"5","key":"2_CR49","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s00213-021-05838-3","volume":"238","author":"OD Howes","year":"2021","unstructured":"Howes OD, Mehta MA (2021) Challenges in CNS drug development and the role of imaging. Psychopharmacology 238(5):1229\u20131230","journal-title":"Psychopharmacology"},{"issue":"7","key":"2_CR50","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1007\/s11095-022-03193-2","volume":"39","author":"KM Huttunen","year":"2022","unstructured":"Huttunen KM, Terasaki T, Urtti A, Montaser AB, Uchida Y (2022) Pharmacoproteomics of brain barrier transporters and substrate design for the brain targeted drug delivery. Pharm Res 39(7):1363\u20131392. https:\/\/doi.org\/10.1007\/s11095-022-03193-2","journal-title":"Pharm Res"},{"issue":"1","key":"2_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12987-020-00230-3","volume":"17","author":"H Kadry","year":"2020","unstructured":"Kadry H, Noorani B, Cucullo L (2020) A blood\u2013brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids Barriers CNS. 17(1):1\u201324. https:\/\/doi.org\/10.1186\/s12987-020-00230-3","journal-title":"Fluids Barriers CNS."},{"issue":"1\u20132","key":"2_CR52","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0006-8993(00)02758-X","volume":"879","author":"T Kageyama","year":"2000","unstructured":"Kageyama T, Nakamura M, Matsuo A, Yamasaki Y, Takakura Y, Hashida M et al (2000) The 4F2hc\/LAT1 complex transports L-DOPA across the blood-brain barrier. Brain Res 879(1\u20132):115\u2013121","journal-title":"Brain Res"},{"issue":"3","key":"2_CR53","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/j.1471-4159.1987.tb00973.x","volume":"49","author":"RN Kalaria","year":"1987","unstructured":"Kalaria RN, Harik SI (1987) Blood-brain barrier monoamine oxidase: enzyme characterization in cerebral microvessels and other tissues from six mammalian species, including human. J Neurochem 49(3):856\u2013864","journal-title":"J Neurochem"},{"issue":"44","key":"2_CR54","doi-asserted-by":"publisher","first-page":"13761","DOI":"10.1523\/JNEUROSCI.4246-09.2009","volume":"29","author":"H Karatas","year":"2009","unstructured":"Karatas H, Aktas Y, Gursoy-Ozdemir Y, Bodur E, Yemisci M, Caban S et al (2009) A nanomedicine transports a peptide caspase-3 inhibitor across the blood-brain barrier and provides neuroprotection. J Neurosci 29(44):13761\u201313769","journal-title":"J Neurosci"},{"issue":"9","key":"2_CR55","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1080\/17425247.2018.1517749","volume":"15","author":"L Kou","year":"2018","unstructured":"Kou L, Sun R, Bhutia YD, Yao Q, Chen R (2018) Emerging advances in P-glycoprotein inhibitory nanomaterials for drug delivery. Expert Opin Drug Deliv 15(9):869\u2013879. https:\/\/doi.org\/10.1080\/17425247.2018.1517749","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"2_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2045-8118-10-25","volume":"10","author":"I Kratzer","year":"2013","unstructured":"Kratzer I, Liddelow SA, Saunders NR, Dziegielewska KM, Strazielle N (2013) Developmental changes in the transcriptome of the rat choroid plexus in relation to neuroprotection. Fluids Barriers CNS 10(1):1","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"2_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12987-021-00303-x","volume":"19","author":"Y Kung","year":"2022","unstructured":"Kung Y, Chen KY, Liao WH, Hsu YH, Wu CH, Hsiao MY et al (2022) Facilitating drug delivery in the central nervous system by opening the blood-cerebrospinal fluid barrier with a single low energy shockwave pulse. Fluids Barriers CNS. 19(1):1\u201313. https:\/\/doi.org\/10.1186\/s12987-021-00303-x","journal-title":"Fluids Barriers CNS."},{"issue":"1","key":"2_CR58","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/10717544.2022.2157068","volume":"30","author":"Y Kung","year":"2023","unstructured":"Kung Y, Wu CH, Lin MT, Liao WH, Chen WS, Hsiao MY (2023) Blood-cerebrospinal fluid barrier opening by modified single pulse transcranial focused shockwave. Drug Deliv 30(1):97\u2013107. https:\/\/doi.org\/10.1080\/10717544.2022.2157068","journal-title":"Drug Deliv"},{"issue":"17","key":"2_CR59","doi-asserted-by":"publisher","first-page":"7612","DOI":"10.1128\/MCB.24.17.7612-7621.2004","volume":"24","author":"M Leggas","year":"2004","unstructured":"Leggas M, Adachi M, Scheffer GL, Sun D, Wielinga P, Du G et al (2004) Mrp4 confers resistance to Topotecan and protects the brain from chemotherapy. Mol Cell Biol 24(17):7612\u20137621","journal-title":"Mol Cell Biol"},{"issue":"3","key":"2_CR60","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/j.1528-1157.1991.tb04671.x","volume":"32","author":"DB Leiderman","year":"1991","unstructured":"Leiderman DB, Balish M, Bromfield EB, Theodore WH (1991) Effect of valproate on human cerebral glucose metabolism. Epilepsia 32(3):417\u2013422","journal-title":"Epilepsia"},{"issue":"8","key":"2_CR61","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nrd4626","volume":"14","author":"L Lin","year":"2015","unstructured":"Lin L, Yee SW, Kim RB, Giacomini KM (2015) SLC transporters as therapeutic targets: emerging opportunities. Nat Rev Drug Discov 14(8):543\u2013560. https:\/\/doi.org\/10.1038\/nrd4626","journal-title":"Nat Rev Drug Discov"},{"issue":"14","key":"2_CR62","doi-asserted-by":"publisher","first-page":"5278","DOI":"10.1073\/pnas.87.14.5278","volume":"87","author":"AE Lindsey","year":"1990","unstructured":"Lindsey AE, Schneider K, Simmons DM, Baron R, Lee BS, Kopito RR (1990) Functional expression and subcellular localization of an anion exchanger cloned from choroid plexus. Proc Natl Acad Sci USA 87(14):5278\u20135282","journal-title":"Proc Natl Acad Sci USA"},{"key":"2_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2017.01005","volume":"8","author":"J Liu","year":"2017","unstructured":"Liu J, Wang F (2017) Role of neuroinflammation in amyotrophic lateral sclerosis: cellular mechanisms and therapeutic implications. Front Immunol 8:1\u201312","journal-title":"Front Immunol"},{"key":"2_CR64","doi-asserted-by":"publisher","first-page":"11(August)","DOI":"10.3389\/fphys.2020.00914","volume":"11","author":"JJ Lochhead","year":"2020","unstructured":"Lochhead JJ, Yang J, Ronaldson PT, Davis TP (2020) Structure, function, and regulation of the blood-brain barrier tight junction in central nervous system disorders. Front Physiol 11:11(August)","journal-title":"Front Physiol"},{"issue":"4","key":"2_CR65","doi-asserted-by":"publisher","first-page":"FSO71","DOI":"10.4155\/fso.15.71","volume":"1","author":"JA Loureiro","year":"2015","unstructured":"Loureiro JA, Gomes B, Coelho MA, Do Carmo Pereira M, Rocha S (2015) Immunoliposomes doubly targeted to transferrin receptor and to \u03b1-synuclein. Futur Sci OA 1(4):FSO71","journal-title":"Futur Sci OA"},{"issue":"3","key":"2_CR66","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.jconrel.2005.03.027","volume":"107","author":"W Lu","year":"2005","unstructured":"Lu W, Zhang Y, Tan YZ, Hu KL, Jiang XG, Fu SK (2005) Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery. J Control Release 107(3):428\u2013448","journal-title":"J Control Release"},{"key":"2_CR67","doi-asserted-by":"publisher","first-page":"119666","DOI":"10.1016\/j.biomaterials.2019.119666","volume":"230","author":"L Lu","year":"2020","unstructured":"Lu L, Zhao X, Fu T, Li K, He Y, Luo Z et al (2020) An iRGD-conjugated prodrug micelle with blood-brain-barrier penetrability for anti-glioma therapy. Biomaterials 230:119666","journal-title":"Biomaterials"},{"key":"2_CR68","doi-asserted-by":"publisher","first-page":"15037","DOI":"10.1038\/mtm.2015.37","volume":"2","author":"HR M\u00e9ndez-G\u00f3mez","year":"2015","unstructured":"M\u00e9ndez-G\u00f3mez HR, Galera-Prat A, Meyers C, Chen W, Singh J, Carri\u00f3n-V\u00e1zquez M et al (2015) Transcytosis in the blood\u2013cerebrospinal fluid barrier of the mouse brain with an engineered receptor\/ligand system. Mol Ther Methods Clin Dev 2:15037","journal-title":"Mol Ther Methods Clin Dev"},{"key":"2_CR69","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4137\/PMC.S13384","volume":"6","author":"JL Mikitsh","year":"2014","unstructured":"Mikitsh JL, Chacko AM (2014) Pathways for small molecule delivery to the central nervous system across the blood-brain barrier. Perspect Medicin Chem 6:11\u201324","journal-title":"Perspect Medicin Chem"},{"issue":"5","key":"2_CR70","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1208\/s12248-017-0110-8","volume":"19","author":"ME Morris","year":"2017","unstructured":"Morris ME, Rodriguez-Cruz V, Felmlee MA (2017) SLC and ABC transporters: expression, localization, and species differences at the blood-brain and the blood-cerebrospinal fluid barriers. AAPS J 19(5):1317\u20131331","journal-title":"AAPS J"},{"issue":"534","key":"2_CR71","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.neulet.2012.11.027","volume":"8","author":"MA Nagle","year":"2013","unstructured":"Nagle MA, Wu W, Eraly SA, Nigam SK (2013) Organic anion transport pathways in antiviral handling in choroid plexus in Oat1 (Slc22a6) and Oat3 (Slc22a8) deficient tissue. Neurosci Lett 8(534):133\u2013138","journal-title":"Neurosci Lett"},{"issue":"2","key":"2_CR72","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.neuroscience.2004.07.051","volume":"129","author":"AT Nies","year":"2004","unstructured":"Nies AT, Jedlitschky G, K\u00f6nig J, Herold-Mende C, Steiner HH, Schmitt HP et al (2004) Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain. Neuroscience 129(2):349\u2013360","journal-title":"Neuroscience"},{"issue":"3","key":"2_CR73","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1083\/jcb.200302070","volume":"161","author":"T Nitta","year":"2003","unstructured":"Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N et al (2003) Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 161(3):653\u2013660","journal-title":"J Cell Biol"},{"issue":"2","key":"2_CR74","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1007\/s12035-015-9672-6","volume":"54","author":"SG Patching","year":"2017","unstructured":"Patching SG (2017) Glucose transporters at the blood-brain barrier: function, regulation and gateways for drug delivery. Mol Neurobiol 54(2):1046\u20131077","journal-title":"Mol Neurobiol"},{"issue":"6500","key":"2_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/science.aaz5626","volume":"369","author":"L Pellegrini","year":"2020","unstructured":"Pellegrini L, Bonfio C, Chadwick J, Begum F, Skehel M, Lancaster MA (2020) Human CNS barrier-forming organoids with cerebrospinal fluid production. Science 369(6500):1\u201321","journal-title":"Science"},{"key":"2_CR76","unstructured":"Pereira P, Barreira M, Cruz C, Tom J, Lu \u00c2, Pedro AQ et al (2020) Brain-targeted delivery of pre-miR-29b using Polyethyleneimine Polyplexes. Pharmaceuticals:1"},{"issue":"3","key":"2_CR77","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s11481-006-9025-3","volume":"1","author":"Y Persidsky","year":"2006","unstructured":"Persidsky Y, Ramirez SH, Haorah J, Kanmogne GD (2006) Blood-brain barrier: structural components and function under physiologic and pathologic conditions. J Neuroimmune Pharmacol 1(3):223\u2013236","journal-title":"J Neuroimmune Pharmacol"},{"issue":"6","key":"2_CR78","doi-asserted-by":"publisher","first-page":"C673","DOI":"10.1152\/ajpcell.00041.2017","volume":"312","author":"J Praetorius","year":"2017","unstructured":"Praetorius J, Damkier HH (2017) Transport across the choroid plexus epithelium. Am J Physiol Cell Physiol 312(6):C673\u2013C686","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"2_CR79","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1152\/ajpcell.00433.2005","volume":"291","author":"J Praetorius","year":"2006","unstructured":"Praetorius J, Nielsen S (2006) Distribution of sodium transporters and aquaporin-1 in the human choroid plexus. Am J Physiol Cell Physiol 291(1):59\u201367","journal-title":"Am J Physiol Cell Physiol"},{"key":"2_CR80","first-page":"1","volume":"13","author":"VM Pulgar","year":"2019","unstructured":"Pulgar VM (2019) Transcytosis to cross the blood brain barrier, new advancements and challenges. Front Neurosci 13:1\u20139","journal-title":"Front Neurosci"},{"key":"2_CR81","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s11095-022-03241-x","volume":"39","author":"E Puris","year":"2022","unstructured":"Puris E, Fricker G, Gynther M (2022) Targeting transporters for drug delivery to the brain: can we do better? Pharm Res 39:1415\u20131455. https:\/\/doi.org\/10.1007\/s11095-022-03241-x","journal-title":"Pharm Res"},{"issue":"4","key":"2_CR82","doi-asserted-by":"publisher","first-page":"3304","DOI":"10.1021\/nn300240p","volume":"6","author":"R Qiao","year":"2012","unstructured":"Qiao R, Jia Q, H\u00fcwel S, Xia R, Liu T, Gao F et al (2012) Receptor-mediated delivery of magnetic nanoparticles across the blood-brain barrier. ACS Nano 6(4):3304\u20133310","journal-title":"ACS Nano"},{"issue":"4","key":"2_CR83","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060199","volume":"8","author":"T Quintela","year":"2013","unstructured":"Quintela T, Goncalves I, Carreto LC, Santos MA, Marcelino H, Patriarca FM et al (2013) Analysis of the effects of sex hormone background on the rat choroid plexus transcriptome by cDNA microarrays. PLoS One 8(4):e60199. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23585832","journal-title":"PLoS One"},{"key":"2_CR84","doi-asserted-by":"publisher","first-page":"102129","DOI":"10.1016\/j.pneurobio.2021.102129","volume":"205","author":"T Quintela","year":"2021","unstructured":"Quintela T, Furtado A, Duarte AC, Gon\u00e7alves I, Myung J, Santos CRA (2021) The role of circadian rhythm in choroid plexus functions. Prog Neurobiol 205:102129","journal-title":"Prog Neurobiol"},{"key":"2_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnins.2019.00521","volume":"13","author":"EM Rhea","year":"2019","unstructured":"Rhea EM, Banks WA (2019) Role of the blood-brain barrier in central nervous system insulin resistance. Front Neurosci 13:1\u201314","journal-title":"Front Neurosci"},{"issue":"2","key":"2_CR86","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/jnr.490310219","volume":"31","author":"K R\u00f6ssler","year":"1992","unstructured":"R\u00f6ssler K, Neuchrist C, Kitz K, Scheiner O, Kraft D, Lassmann H (1992) Expression of leucocyte adhesion molecules at the human blood-brain barrier (BBB). J Neurosci Res 31(2):365\u2013374","journal-title":"J Neurosci Res"},{"issue":"21","key":"2_CR87","doi-asserted-by":"publisher","first-page":"17745","DOI":"10.1021\/acsami.7b03682","volume":"9","author":"H Ruan","year":"2017","unstructured":"Ruan H, Chen X, Xie C, Li B, Ying M, Liu Y et al (2017) Stapled RGD peptide enables glioma-targeted drug delivery by overcoming multiple barriers. ACS Appl Mater Interfaces 9(21):17745\u201317756","journal-title":"ACS Appl Mater Interfaces"},{"key":"2_CR88","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.yfrne.2016.12.002","volume":"44","author":"CRA Santos","year":"2017","unstructured":"Santos CRA, Duarte AC, Quintela T, Tom\u00e1s J, Albuquerque T, Marques F et al (2017) The choroid plexus as a sex hormone target: functional implications. Front Neuroendocrinol 44:103\u2013121","journal-title":"Front Neuroendocrinol"},{"key":"2_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2019.101680","volume":"182","author":"CRA Santos","year":"2019","unstructured":"Santos CRA, Duarte AC, Costa AR, Tom\u00e1s J, Quintela T, Gon\u00e7alves I (2019) The senses of the choroid plexus. Prog Neurobiol 182:101680. https:\/\/doi.org\/10.1016\/j.pneurobio.2019.101680","journal-title":"Prog Neurobiol"},{"issue":"1","key":"2_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2040-2384-2-14","volume":"2","author":"H Sarin","year":"2010","unstructured":"Sarin H (2010) Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability. J Angiogenes Res 2(1):1\u201319","journal-title":"J Angiogenes Res"},{"key":"2_CR91","doi-asserted-by":"crossref","unstructured":"Sato R, Ohmori K, Umetsu M, Takao M, Tano M, Grant G et al (2021) An atlas of the quantitative protein expression of anti-epileptic-drug transporters, metabolizing enzymes and tight junctions at the blood-brain barrier in epileptic patients. Pharmaceutics. 13(12)","DOI":"10.3390\/pharmaceutics13122122"},{"issue":"1","key":"2_CR92","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/2045-8118-9-6","volume":"9","author":"A Schrade","year":"2012","unstructured":"Schrade A, Sade H, Couraud PO, Romero IA, Weksler BB, Niewoehner J (2012) Expression and localization of claudins-3 and -12 in transformed human brain endothelium. Fluids Barriers CNS. 9(1):2\u20136","journal-title":"Fluids Barriers CNS."},{"issue":"4","key":"2_CR93","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1021\/mp200129p","volume":"8","author":"R Shawahna","year":"2011","unstructured":"Shawahna R, Uchida Y, Decl\u00e8ves X, Ohtsuki S, Yousif S, Dauchy S et al (2011) Transcriptomic and quantitative proteomic analysis of transporters and drug metabolizing enzymes in freshly isolated human brain microvessels. Mol Pharm 8(4):1332\u20131341","journal-title":"Mol Pharm"},{"issue":"4","key":"2_CR94","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1523\/JNEUROSCI.1432-18.2018","volume":"39","author":"N Sladojevic","year":"2019","unstructured":"Sladojevic N, Stamatovic SM, Johnson AM, Choi J, Hu A, Dithmer S et al (2019) Claudin-1-dependent destabilization of the blood\u2013brain barrier in chronic stroke. J Neurosci 39(4):743\u2013757","journal-title":"J Neurosci"},{"issue":"1","key":"2_CR95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12987-020-00196-2","volume":"17","author":"P Sol\u00e1r","year":"2020","unstructured":"Sol\u00e1r P, Zamani A, Kub\u00ed\u010dkov\u00e1 L, Dubov\u00fd P, Joukal M (2020) Choroid plexus and the blood-cerebrospinal fluid barrier in disease. Fluids Barriers CNS. 17(1):1\u201329. https:\/\/doi.org\/10.1186\/s12987-020-00196-2","journal-title":"Fluids Barriers CNS."},{"issue":"24","key":"2_CR96","doi-asserted-by":"publisher","first-page":"20410","DOI":"10.1021\/acsami.7b03504","volume":"9","author":"Y Song","year":"2017","unstructured":"Song Y, Du D, Li L, Xu J, Dutta P, Lin Y (2017) In vitro study of receptor-mediated silica nanoparticles delivery across blood-brain barrier. ACS Appl Mater Interfaces 9(24):20410\u201320416","journal-title":"ACS Appl Mater Interfaces"},{"key":"2_CR97","doi-asserted-by":"crossref","unstructured":"Song J, Lu C, Leszek J, Zhang J (2021) Design and development of nanomaterial-based drug carriers to overcome the blood\u2013brain barrier by using different transport mechanisms. Int J Mol Sci 22(18)","DOI":"10.3390\/ijms221810118"},{"issue":"1","key":"2_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-04677-9","volume":"9","author":"AB Steffensen","year":"2018","unstructured":"Steffensen AB, Oernbo EK, Stoica A, Gerkau NJ, Barbuskaite D, Tritsaris K et al (2018) Cotransporter-mediated water transport underlying cerebrospinal fluid formation. Nat Commun 9(1):1\u201313. https:\/\/doi.org\/10.1038\/s41467-018-04677-9","journal-title":"Nat Commun"},{"issue":"5","key":"2_CR99","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1021\/mp300518e","volume":"10","author":"N Strazielle","year":"2013","unstructured":"Strazielle N, Ghersi-Egea JF (2013) Physiology of blood-brain interfaces in relation to brain disposition of small compounds and macromolecules. Mol Pharm 10(5):1473\u20131491","journal-title":"Mol Pharm"},{"key":"2_CR100","doi-asserted-by":"publisher","first-page":"5463","DOI":"10.2174\/1381612822666160726112115","volume":"22","author":"N Strazielle","year":"2016","unstructured":"Strazielle N, Ghersi-Egea J-F (2016) Potential pathways for CNS drug delivery across the blood-cerebrospinal fluid barrier. Curr Pharm Des 22:5463\u20135476","journal-title":"Curr Pharm Des"},{"issue":"12","key":"2_CR101","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.addr.2004.07.006","volume":"56","author":"N Strazielle","year":"2004","unstructured":"Strazielle N, Khuth ST, Ghersi-Egea JF (2004) Detoxification systems, passive and specific transport for drugs at the blood-CSF barrier in normal and pathological situations. Adv Drug Deliv Rev 56(12):1717\u20131740","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"2_CR102","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1208\/s12248-021-00587-9","volume":"23","author":"A Sun","year":"2021","unstructured":"Sun A, Wang J (2021) Choroid plexus and drug removal mechanisms. AAPS J 23(3):61","journal-title":"AAPS J"},{"key":"2_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fncel.2021.661838","volume":"15","author":"F Takata","year":"2021","unstructured":"Takata F, Nakagawa S, Matsumoto J, Dohgu S (2021) Blood-brain barrier dysfunction amplifies the development of Neuroinflammation: understanding of cellular events in brain microvascular endothelial cells for prevention and treatment of BBB dysfunction. Front Cell Neurosci 15:1\u201324","journal-title":"Front Cell Neurosci"},{"issue":"4","key":"2_CR104","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1085\/jgp.201411164","volume":"143","author":"J ter Beek","year":"2014","unstructured":"ter Beek J, Guskov A, Slotboom DJ (2014) Structural diversity of ABC transporters. J Gen Physiol 143(4):419\u2013435","journal-title":"J Gen Physiol"},{"issue":"5","key":"2_CR105","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41573-021-00139-y","volume":"20","author":"GC Terstappen","year":"2021","unstructured":"Terstappen GC, Meyer AH, Bell RD, Zhang W (2021) Strategies for delivering therapeutics across the blood\u2013brain barrier. Nat Rev Drug Discov 20(5):362\u2013383. https:\/\/doi.org\/10.1038\/s41573-021-00139-y","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"2_CR106","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1152\/physrev.00001.2003","volume":"83","author":"PL Tuma","year":"2003","unstructured":"Tuma PL, Hubbard AL (2003) Transcytosis: crossing cellular barriers. Physiol Rev 83(3):871\u2013932","journal-title":"Physiol Rev"},{"issue":"2","key":"2_CR107","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1471-4159.2011.07208.x","volume":"117","author":"Y Uchida","year":"2011","unstructured":"Uchida Y, Ohtsuki S, Katsukura Y, Ikeda C, Suzuki T, Kamiie J et al (2011) Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors. J Neurochem 117(2):333\u2013345","journal-title":"J Neurochem"},{"issue":"3","key":"2_CR108","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1007\/s12035-018-1207-5","volume":"56","author":"Y Uchida","year":"2019","unstructured":"Uchida Y, Sumiya T, Tachikawa M, Yamakawa T, Murata S, Yagi Y et al (2019) Involvement of Claudin-11 in disruption of blood-brain, -spinal cord, and -arachnoid barriers in multiple sclerosis. Mol Neurobiol 56(3):2039\u20132056","journal-title":"Mol Neurobiol"},{"key":"2_CR109","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/jnc.13758","volume":"139","author":"T Usui","year":"2016","unstructured":"Usui T, Nakazawa A, Okura T, Deguchi Y, Akanuma S, Kubo Y et al (2016) Histamine elimination from the cerebrospinal fluid across the blood-cerebropsinal fluid barrier: involvement of plasma membrane monoamine transporter (PMAT\/SLC29A4). J Neurochem 139:408\u2013418","journal-title":"J Neurochem"},{"issue":"1","key":"2_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40635-018-0203-4","volume":"6","author":"D Vermette","year":"2018","unstructured":"Vermette D, Hu P, Canarie MF, Funaro M, Glover J, Pierce RW (2018) Tight junction structure, function, and assessment in the critically ill: a systematic review. Intensive Care Med Exp 6(1):1\u201318","journal-title":"Intensive Care Med Exp"},{"issue":"10","key":"2_CR111","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2174\/13816128113199990462","volume":"20","author":"N Vijay","year":"2014","unstructured":"Vijay N, Morris ME (2014) Role of monocarboxylate transporters in drug delivery to the brain. Curr Pharm Des 20(10):1487\u20131498","journal-title":"Curr Pharm Des"},{"issue":"12","key":"2_CR112","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1177\/002215540205001212","volume":"50","author":"D Virgintino","year":"2002","unstructured":"Virgintino D, Robertson D, Errede M, Benagiano V, Girolamo F, Maiorano E et al (2002) Expression of P-glycoprotein in human cerebral cortex microvessels. J Histochem Cytochem 50(12):1671\u20131676","journal-title":"J Histochem Cytochem"},{"issue":"3","key":"2_CR113","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/BF01190839","volume":"18","author":"AW Vorbrodt","year":"1989","unstructured":"Vorbrodt AW (1989) Ultracytochemical characterization of anionic sites in the wall of brain capillaries. J Neurocytol 18(3):359\u2013368","journal-title":"J Neurocytol"},{"issue":"5","key":"2_CR114","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/cpt.442","volume":"100","author":"J Wang","year":"2016","unstructured":"Wang J (2016) The plasma membrane monoamine transporter (PMAT): structure, function, and role in organic cation disposition. Clin Pharmacol Ther 100(5):489\u2013499","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"2_CR115","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1080\/17425255.2018.1513493","volume":"14","author":"Q Wang","year":"2018","unstructured":"Wang Q, Zuo Z (2018) Impact of transporters and enzymes from blood\u2013cerebrospinal fluid barrier and brain parenchyma on CNS drug uptake. Expert Opin Drug Metab Toxicol 14(9):961\u2013972. https:\/\/doi.org\/10.1080\/17425255.2018.1513493","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"1","key":"2_CR116","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-022-02456-4","volume":"19","author":"J Wang","year":"2022","unstructured":"Wang J, Liu R, Hasan MN, Fischer S, Chen Y, Como M et al (2022) Role of SPAK\u2013NKCC1 signaling cascade in the choroid plexus blood\u2013CSF barrier damage after stroke. J Neuroinflammation 19(1):1\u201319. https:\/\/doi.org\/10.1186\/s12974-022-02456-4","journal-title":"J Neuroinflammation"},{"issue":"3","key":"2_CR117","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1172\/JCI8267","volume":"105","author":"J Wijnholds","year":"2000","unstructured":"Wijnholds J, De Lange ECM, Scheffer GL, Van Den Berg DJ, Mol CAAM, Van Der Valk M et al (2000) Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier. J Clin Invest 105(3):279\u2013285","journal-title":"J Clin Invest"},{"issue":"4","key":"2_CR118","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/jcb.20555","volume":"96","author":"HY Wong","year":"2005","unstructured":"Wong HY, Chu TS, Lai JC, Fung KP, Fok TF, Fujii T et al (2005) Sodium valproate inhibits glucose transport and exacerbates Glut1-deficiency in vitro. J Cell Biochem 96(4):775\u2013785","journal-title":"J Cell Biochem"},{"issue":"6","key":"2_CR119","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1080\/10611860902963013","volume":"17","author":"F Xu","year":"2009","unstructured":"Xu F, Lu W, Wu H, Fan L, Gao X, Jiang X (2009) Brain delivery and systemic effect of cationic albumin conjugated PLGA nanoparticles. J Drug Target 17(6):423\u2013434","journal-title":"J Drug Target"},{"issue":"1","key":"2_CR120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-4598-13-191","volume":"13","author":"PJ Yue","year":"2014","unstructured":"Yue PJ, He L, Qiu SW, Li Y, Liao YJ, Li XP et al (2014) OX26\/CTX-conjugated PEGylated liposome as a dual-targeting gene delivery system for brain glioma. Mol Cancer 13(1):1\u201313","journal-title":"Mol Cancer"},{"issue":"1","key":"2_CR121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-022-02530-x","volume":"19","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Tan Q, Guo P, Huang S, Jia Z, Liu X et al (2022) NLRP3 inflammasome-mediated choroid plexus hypersecretion contributes to hydrocephalus after intraventricular hemorrhage via phosphorylated NKCC1 channels. J Neuroinflammation 19(1):1\u201322. https:\/\/doi.org\/10.1186\/s12974-022-02530-x","journal-title":"J Neuroinflammation"},{"key":"2_CR122","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/B978-0-12-814001-7.00007-X","volume-title":"Brain targeted drug delivery systems: a focus on nanotechnology and nanoparticulates","author":"X Zhu","year":"2018","unstructured":"Zhu X, Jin K, Huang Y, Pang Z (2018) Brain drug delivery by adsorption-mediated transcytosis. In: Brain targeted drug delivery systems: a focus on nanotechnology and nanoparticulates. Elsevier Ltd., pp 159\u2013183. https:\/\/doi.org\/10.1016\/B978-0-12-814001-7.00007-X"}],"container-title":["Application of Nanocarriers in Brain Delivery of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-97-2859-6_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T04:02:45Z","timestamp":1725595365000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-981-97-2859-6_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9789819728589","9789819728596"],"references-count":122,"URL":"https:\/\/doi.org\/10.1007\/978-981-97-2859-6_2","relation":{},"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"7 September 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}